Ledger.Open graph →
SEC Form D · filed January 5, 2017

GeneCentric Diagnostics, Inc

Offering
$8.6M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Clay N. Thorp · Durham, NCDirectorMyla Lai-Goldman · Durham, NCExec · DirectorArnold N. Levine · Durham, NCDirectorDavid N. Hayes · Durham, NCExec · DirectorCharles N. Perou · Durham, NCDirectorMichael A. Costa · San Francisco, CADirectorDavid Sams · Santa Monica, CAExec · DirectorWilliam Eimicke · Santa Monica, CADirectorFarrell M. Ender · Philadelphia, PADirectorDean B. Drysdale · Langley, British Columbia, CanadaExec · DirectorMukesh K. Parekh · SANTA MONICA, CADirectorMark J. Minichello · BOSTON, MAExec · DirectorVlad B. Portnoy · New York, NYExec · DirectorMark W. Martin · Porter, TXDirectorChristopher Cutter · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗